Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Inquiry Memorial
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Support and FAQs
    • NHS Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Hepatitis C Testing
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Diana Walford stated that "if somebody applied to the Medicines Division or the licensing authority, as they actually were deemed, for a clinical trial certificate or a clinical trial exemption certificate that was to be considered. It fell to be considered by Medicines Division, whether it needed to go entirely to a Committee on Safety of Medicines Meeting I think might have depended on the product."

Published on: 23 July, 2024

It appeared that there was no site examination at any of the blood collection centres in the USA.

Published on: 23 July, 2024

Dr Diana Walford recalled that upon visiting a USA manufacturing facility, the inspector and herself were very unhappy due to the lack of hygiene among other things.

Published on: 23 July, 2024

The Department of Health and Social Security was of the view that hepatitis was a serious disease and unless the intention was to process the plasma separately it would be impossible to prevent contamination of the UK material with imported hepatitis viruses.

Published on: 24 July, 2024

Dr Walford told the Inquiry that she felt not everyone at the DHSS was as aware that NANBH could give rise to chronic liver disease and this was why she had shared her comment with senior people

Published on: 16 August, 2024

In her evidence Dr Walford agreed that it was or should have been known to all those involved with BPL in the second half of the 1970s that the demand for blood products was rising, that it was or should have been obvious that BPL was outdated and too small, and that significant investment was required in order to be able to meet the rising demand, and that the Government had determined that BPL should meet standards equivalent to those expected of commercial plants.

Published on: 30 August, 2024

According to Dr Diana Walford's oral evidence, during her time at the Med SEB it was apparent that the transmission of non-A non-B hepatitis from blood products was a significant problem and had the potential to lead to chronic liver disease.

Published on: 24 September, 2024

According to Dr Diana Walford's oral evidence to the Inquiry, she wrote a minute to Mr Harley and spoke "quite forcibly" about the lack of awareness of the potential that Non-A, Non-B Hepatitis could cause severe chronic disease.

Published on: 24 September, 2024

According to Dr Diana Walford's oral evidence, the DHSS did not take any steps to ensure that clinicians, patients cohorts or representative bodies such as the Haemophilia Society were aware of the serious nature of Non-A, Non-B Hepatitis because the DHSS relied on clinicians as professionals to make themselves aware of issues.

Published on: 24 September, 2024

In her oral evidence, Dr Diana Walford indicated that on questions of treatment risks and benefits, the DHSS was guided by and deferred to the UKHCDO's views as it represented the group with relevant expertise.

Published on: 24 September, 2024

Dr Morag Chisholm protested to Dr Aronstam "many times" that she did not want concentrate used on patients, but was told it was needed.

Published on: 16 July, 2024

The parents of Gary Bennett, a Treloar's student, were not informed of the DDVAP trial.

Published on: 16 July, 2024

John Peach, parent of a student at Treloar's, was never told that his son was being given commercial concentrate.

Published on: 16 July, 2024

John Peach, parent of a student at Treloar's, was not told that prophylaxis was trialled on his son.

Published on: 16 July, 2024

John Peach, parent of a student at Treloar's, was not told as soon as his son developed hepatitis.

Published on: 16 July, 2024

Jason Peach, a student at Treloar's, was treated with commercial concentrate without his parents' knowledge and without them being informed of risk. The parents were only made aware of the possibility of their child going "yellow" with "a bit of jaundice", which they understood to be both mild and unavoidable.

Published on: 16 July, 2024

Nick Sainsbury remembered the Headmaster at Treloar's, Mr Macpherson, telling students not to worry hepatitis because they had the mild type.

Published on: 16 July, 2024

Jason Peach, a student at Treloar's, was never told by Treloar's school of his infections and instead he learned via his home centre, the Oxford Haemophilia Centre.

Published on: 16 July, 2024

Gary Bennett, a student at Treloar's, learnt of his infections from his home doctor, Dr Chisholm.

Published on: 16 July, 2024

The parents of Lee Stay, a pupil at Treloar's, were not involved with his treatment at the school.

Published on: 16 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2381
  • Page 2382
  • Page 2383
  • Page 2384
  • Current page 2385
  • Page 2386
  • Page 2387
  • Page 2388
  • Page 2389
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.